Qualigen Therapeutics, Inc. (QLGN) shares are surging more than 47 percent on Tuesday morning trade, continuing an upsurge since November 18. There were no corporate announcements on the day to impact the stock movement.
On November 15, the company has reported a 47 percent increase in third-quarter revenue to $1.2 million from 40.8 million a year ago, on higher unit volume of product sale.
Currently, shares are at $1.84, up 47 percent from the previous close of $1.25 on a volume of 25,116,559. For the 52-week period, the share have traded in a range of $0.93-$4.66 on average volume of 1,024,928.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.